Associate Professor Wigg graduated in Medicine from Adelaide University in 1992. He obtained his fellowship from the Royal Australian College of Physicians in 1999, as a specialist in Gastroenterology and Hepatology. He then completed a PhD at Flinders University, studying hepatocyte culture in bioartificial liver devices, in 2004. Post doctural studies occured at the Queen Elizabeth Hospital Liver Transplant Unit, Birmingham, United Kingdom in 2004. During 2013-14 Associate Professor Wigg also undertook further post doctoral training at the University of Rome Tor Vergata.
2014- Associate Professor, Flinders University
2006- Senior Lecturer, Flinders University
2004- PhD, Flinders University
1999- Fellow of the Royal Australian College of Physicians
1992-MBBS, Adelaide University
Awards and Prizes
2018: Ranked number one/Field Leader for Gastroenterology and Hepatology Research. The Stars of 2018- Australia's Field Leaders in Health and Medical Sciences. The Australian Newspaper, Septmeber 2018.
2015: Winner Southern Adelaide Local Health Network Excellence Award Dision of Surgery: The Liver failure Program.
2016: Southern Adelaide Local Health Network Clinical Excellence Award for Access to Care; The Hepatitis Outreach Program.
2011: Oral presentation at American Association for the Study of Liver Diseases, Annual Meeting. Randomized pilot trial of a chronic disease management intervention in chronic liver failure.
2003: Mark Jolley Travelling Fellowship Award ($2,000 award from South Australian Postgraduate Association for overseas travel)
2003: AstraZeneca Career Development Award 2003 ($50,000 award for 12 month clinical research program).
2003: Flinders Medical Research Institute Scientific communication Award. Flinders Medical Research Institute Research Day.
2001: Finalist Asia Pacific Association of Gastroenterology Young Clinician Award (Asia Pacific Digestive Diseases Week, Sydney)
2019: Chief Investigator (CIA) NH&MRC Partnership Grant (APP 1170032). Total value: $ 984,000.
2018: Gastroenterology Society of Australia Inaugural Philanthropic Grant for the sustainable improvement of Australian GI healthcare in a rural or disadvantaged setting. $11,000.
2018: Gilead Sciences Grant. Prevalence of HCC and HBV in Aboriginal populations of South Australia.
2017: MSD Grant, Prevalence of hepatitis C in psychiatric inpatients. $100,000.
2015: Abbvie and Norgine grants: Hepatitis Outreach Programs in rural South Australia.
2013: FMC Foundation Research Seeding Grant, $10,000, Predictors of hepatocellular carcinoma recurrence post thermal ablation.
2013: FMC Foundation Research Seeding Grant, $14,000, Liver Transplant Outcomes in an Indigenous Australian Population.
2009: Pillar Research Grant, Roche, $10,000, Impact of a Liver Failure Service for Patients with Cirrhosis.
2009: FMC Foundation Research Seeding Grant, $13,000, The influence of recipient and donor genetics on the pharmacokinetics of tacrolimus after liver transplantation.
2000-2002: NH&MRC Postgraduate Medical Scholarship.
Publication Award - OCT 2015
Dr Wigg's main professional and community engagement comes from his active membership of the Adelaide Liver Research Group (Co-convenor) and the Australian Liver Association (prior executive committee member).
You consent to the use of our cookies if you proceed.